Related Experiment Video
Updated: Nov 19, 2025
09:02
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.9K
Correction: PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities.
Yajie Zhang1, Miguel García-Gabilondo, Alba Grayston
1Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Catalonia, 08193 Bellaterra, Spain. anna.roig@csic.es.
Nanoscale
|February 1, 2021
Summary
This correction clarifies details for PLGA protein nanocarriers used in multimodal imaging. It ensures accurate reporting for fluorescence, MRI, and PET imaging applications.
Area of Science:
- Biomedical Engineering
- Materials Science
- Nanotechnology
Background:
- Poly(lactic-co-glycolic acid) (PLGA) nanocarriers are utilized for drug delivery and imaging.
- Multimodal imaging combines different techniques for comprehensive biological analysis.
Purpose of the Study:
- To correct and clarify information presented in the original article regarding PLGA protein nanocarriers.
- To ensure accurate representation of fluorescence, Magnetic Resonance Imaging (MRI), and Positron Emission Tomography (PET) imaging modalities.
Main Methods:
- Review and re-evaluation of experimental data and descriptions.
- Correction of specific details related to nanocarrier formulation and imaging probe integration.
Main Results:
- The correction ensures the fidelity of data reported for PLGA nanocarriers.
- Accurate parameters for fluorescence, MRI, and PET imaging are now presented.
Conclusions:
- The corrected information provides a reliable basis for future research using these tailor-made nanocarriers.
- Ensures the reproducibility and accurate interpretation of studies employing these multimodal imaging agents.
